Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ju. E. Tatsii"'
Autor:
M. M. Loukianov, S. Yu. Martsevich, E. Yu. Andrenko, S. S. Yakushin, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, Е. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. M. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 5, Pp 702-711 (2021)
Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials
Externí odkaz:
https://doaj.org/article/e9b6d3b313304148a6caa15308d1e5d5
Autor:
M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 6, Pp 888-898 (2020)
Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom como
Externí odkaz:
https://doaj.org/article/cfdcd982a2af41b792e5349981d3ba70
Autor:
S. Yu. Martsevich, E. V. Kudryashov, M. M. Loukianov, T. A. Gomova, Е. Yu. Okshina, V. V. Yakusevich, V. G. Klyashtorny, V. P. Mikhin, A. V. Zagrebelny, Oxana Drapkina, E. N. Belova, E. Yu. Andrenko, A. N. Makoveeva, K. G. Pereverzeva, M. M. Valiakhmetov, Sergey Boytsov, Ju. E. Tatsii, S. S. Yakushin, A. N. Vorobiev, Yu. V. Maslennikova, E. M. Pozdnyakova, E. E. Fedotova
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 5, Pp 702-711 (2021)
Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials
Autor:
V. P. Mikhin, A. N. Vorobyev, Yu. V. Maslennikova, E. V. Kudryashov, E. E. Fedotova, Sergey Boytsov, V. V. Yakusevich, Oxana Drapkina, E. Yu. Andreenko, Ju. E. Tatsii, S. S. Yakushin, V. G. Klyashtorny, E. M. Pozdnyakova, M. M. Loukianov, E. Yu. Okshina, S. Yu. Martsevich, T. A. Gomova, K. G. Pereverzeva, A. V. Zagrebelnyy, M. N. Valiakhmetov
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 6, Pp 888-898 (2020)
Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom como